Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 262

1.

Differential expression of myc, max and RB1 genes in human gliomas and glioma cell lines.

Hirvonen HE, Salonen R, Sandberg MM, Vuorio E, Västrik I, Kotilainen E, Kalimo H.

Br J Cancer. 1994 Jan;69(1):16-25.

2.

Expression of oligodendrocytic mRNAs in glial tumors: changes associated with tumor grade and extent of neoplastic infiltration.

Landry CF, Verity MA, Cherman L, Kashima T, Black K, Yates A, Campagnoni AT.

Cancer Res. 1997 Sep 15;57(18):4098-104.

4.

Activation domains of L-Myc and c-Myc determine their transforming potencies in rat embryo cells.

Barrett J, Birrer MJ, Kato GJ, Dosaka-Akita H, Dang CV.

Mol Cell Biol. 1992 Jul;12(7):3130-7.

5.

Expression of L-myc and N-myc proto-oncogenes in human leukemias and leukemia cell lines.

Hirvonen H, Hukkanen V, Salmi TT, Mäkelä TP, Pelliniemi TT, Knuutila S, Alitalo R.

Blood. 1991 Dec 1;78(11):3012-20.

6.
7.

Lack of correlation between N-myc and MAX expression in neuroblastoma tumors and in cell lines: implication for N-myc-MAX complex formation.

Raschella G, Romeo A, Negroni A, Pucci S, Dominici C, Castello MA, Bevilacqua P, Felsani A, Calabretta B.

Cancer Res. 1994 Apr 15;54(8):2251-5.

8.

myc, max, and a novel rlf-L-myc fusion protein in small-cell lung cancer.

Västrik I, Mäkelä TP, Koskinen PJ, Saksela K, Alitalo K.

Princess Takamatsu Symp. 1991;22:307-18. Review.

PMID:
1668890
9.

Differential regulation of Max and role of c-Myc during erythroid and myelomonocytic differentiation of K562 cells.

Delgado MD, Lerga A, Cañelles M, Gómez-Casares MT, León J.

Oncogene. 1995 Apr 20;10(8):1659-65.

PMID:
7731722
10.

Expression of myc-family, myc-interacting, and myc-target genes during preimplantation mouse development.

Domashenko AD, Latham KE, Hatton KS.

Mol Reprod Dev. 1997 May;47(1):57-65.

PMID:
9110315
11.

Expression of the myc-family proto-oncogenes and related genes max and mad in synovial tissue.

Roivainen A, Pirilä L, Yli-Jama T, Laaksonen H, Toivanen P.

Scand J Rheumatol. 1999;28(5):314-8.

PMID:
10568429
12.

The N-myc oncoprotein is a transcriptional activator and associates with max and RB1 proteins.

Wenzel A, Cziepluch C, Schürmann J, Schwab M.

Prog Clin Biol Res. 1994;385:59-66. No abstract available.

PMID:
7972238
13.

Specific c-myc and max regulation in epithelial cells.

Martel C, Lallemand D, Crémisi C.

Oncogene. 1995 Jun 1;10(11):2195-205.

PMID:
7784064
14.

Variant Max protein, derived by alternative splicing, associates with c-Myc in vivo and inhibits transactivation.

Arsura M, Deshpande A, Hann SR, Sonenshein GE.

Mol Cell Biol. 1995 Dec;15(12):6702-9.

15.
16.

Transcriptional regulation of the ornithine decarboxylase gene by c-Myc/Max/Mad network and retinoblastoma protein interacting with c-Myc.

Auvinen M, Järvinen K, Hotti A, Okkeri J, Laitinen J, Jänne OA, Coffino P, Bergman M, Andersson LC, Alitalo K, Hölttä E.

Int J Biochem Cell Biol. 2003 Apr;35(4):496-521.

PMID:
12565711
17.

Synergistic induction of the Fas (CD95) ligand promoter by Max and NFkappaB in human non-small lung cancer cells.

Wiener Z, Ontsouka EC, Jakob S, Torgler R, Falus A, Mueller C, Brunner T.

Exp Cell Res. 2004 Sep 10;299(1):227-35.

PMID:
15302589
19.

c-Myc inactivation by mutant Max alters growth and morphology of NCI-H-630 colon cancer cells.

Borrè A, Cultraro CM, Segal S.

J Cell Physiol. 1996 Oct;169(1):200-8.

PMID:
8841436
20.

Hemizygosity of the MAX gene locus in HL60 cells.

Ryan KM, al-Mulla F, Jamieson T, Birnie GD.

Cancer Genet Cytogenet. 1998 Dec;107(2):93-7.

PMID:
9844600

Supplemental Content

Support Center